Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 14,182 $ 4,353
Prepaid expenses and other current assets 313 331
Total current assets 14,495 4,684
Capitalized software development costs, net 3,741 3,990
ERC receivable 1,528 1,528
Property and equipment, net 60 43
Operating lease right-of-use assets 208 218
Intangible assets, net 135 117
Other assets 259 259
Total assets 20,426 10,839
Current liabilities    
Accounts payable 1,083 1,408
Accrued expenses 2,593 2,324
Accrued payroll 376 420
Accrued officers’ salary 901 648
Notes payable, current 1,024 1,787
Accrued interest 44 533
Operating lease liabilities, current 70 67
Preferred dividend payable 75
Derivative liability 2 1
Total current liabilities 6,168 7,188
Long-term liabilities    
Notes payable, non-current 113 362
Operating lease liabilities, non-current 144 164
Total liabilities 6,425 7,714
Commitments and contingencies (Note 12)
Stockholders’ equity    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 79,300,788 and 21,231,355 shares issued and outstanding as of March 31, 2024 and December 31, 2023 8 2
Additional paid-in capital 190,155 175,765
Accumulated deficit (179,142) (175,622)
Total stockholders’ equity 14,001 3,125
Total liabilities and stockholders’ equity 20,426 10,839
Series C Preferred Stock [Member]    
Stockholders’ equity    
Series C Preferred Stock, $0.0001 par value, 5,000 shares authorized, 3,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023 2,980 2,980
Common Class A [Member]    
Stockholders’ equity    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 79,300,788 and 21,231,355 shares issued and outstanding as of March 31, 2024 and December 31, 2023